Share Price and Basic Stock Data
Last Updated: December 24, 2025, 8:37 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Cinevista Ltd operates in the entertainment and media industry, with a current market capitalization of ₹88.2 Cr and a share price standing at ₹15.4. The company has faced significant revenue challenges in recent years, with reported sales declining from ₹52 Cr in March 2014 to just ₹1 Cr in March 2023. The most recent quarterly sales data reflects meager figures, with ₹0.43 Cr reported in September 2023 and ₹0.01 Cr in March 2024, indicating ongoing struggles in generating consistent revenue streams. However, projections for March 2025 suggest a rebound with sales expected to reach ₹12 Cr, signaling potential recovery as the company transitions from a prolonged period of stagnation. Despite this, the trailing twelve months (TTM) revenue stands at ₹20 Cr, further emphasizing the volatility of Cinevista’s operational performance.
Profitability and Efficiency Metrics
Cinevista’s profitability metrics reveal a challenging landscape, with operating profit margins (OPM) fluctuating significantly. The OPM stood at -4,942% in March 2023, reflecting the severe losses the company endured, with an operating profit of -₹40 Cr. The latest available data shows an OPM of 41.90% in June 2025, indicating a potential turnaround. However, net profit figures remain concerning, with a net loss of ₹25.87 Cr reported for March 2025. The interest coverage ratio (ICR) is particularly low at -4.76x, suggesting that the company struggles to meet its interest obligations. The return on equity (ROE) is reported at 47.7%, which is notably high, but this is largely due to the company’s negative equity position. Overall, while there are signs of improving margins, the profitability landscape remains precarious.
Balance Sheet Strength and Financial Ratios
The balance sheet of Cinevista reveals a complex financial situation. The company holds ₹40 Cr in reserves against borrowings of ₹23 Cr, indicating a manageable level of debt relative to its equity capital, which is constant at ₹12 Cr. However, the price-to-book value (P/BV) ratio stands at -2.04x, highlighting negative book value per share of ₹6.77 as of March 2025. This negative valuation is compounded by a current ratio of 1.59, suggesting adequate liquidity to cover short-term liabilities. Nevertheless, the long-term debt-to-equity ratio is notably negative at -0.61, indicating potential solvency issues. In terms of efficiency, the cash conversion cycle (CCC) is extremely high at 2,329 days, which raises concerns about the company’s operational efficiency and ability to convert sales into cash effectively.
Shareholding Pattern and Investor Confidence
Cinevista’s shareholding structure shows a dominant promoter stake of 67.43%, which has remained stable over recent quarters, providing a degree of investor confidence in management continuity. Public ownership comprises 32.57%, with a total of 12,953 shareholders as of the latest reporting. The stability in promoter ownership suggests a commitment to the company’s long-term strategy, even amidst financial adversity. However, the absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) indicates a potential lack of broader institutional interest, which could reflect concerns regarding the company’s financial health. The gradual increase in the number of shareholders from 11,821 in December 2022 to 12,953 in September 2025 may indicate growing interest from retail investors, albeit amid underlying risks.
Outlook, Risks, and Final Insight
The outlook for Cinevista is cautiously optimistic, with potential for revenue recovery as indicated by the anticipated sales growth to ₹12 Cr in March 2025. However, significant risks remain, including ongoing operational inefficiencies, high cash conversion cycle, and negative profit margins. The company’s ability to stabilize its financial performance will be critical; a failure to do so could further erode investor confidence and lead to increased volatility in share price. On the other hand, if Cinevista can effectively leverage its high ROE and improve profitability metrics, it may attract more institutional interest and foster a more robust financial recovery. The next few quarters will be pivotal in determining whether Cinevista can capitalize on its current trajectory or if it will continue to face substantial headwinds in the competitive entertainment sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hathway Bhawani Cabletel & Datacom Ltd | 10.9 Cr. | 13.5 | 21.7/13.0 | 68.2 | 2.19 | 0.00 % | 3.38 % | 2.25 % | 10.0 |
| G V Films Ltd | 83.9 Cr. | 0.45 | 0.75/0.30 | 0.61 | 0.00 % | 2.36 % | 2.68 % | 1.00 | |
| Encash Entertainment Ltd | 11.3 Cr. | 29.0 | / | 20.3 | 0.00 % | 4.70 % | 4.70 % | 10.0 | |
| Diksat Transworld Ltd | 211 Cr. | 120 | 148/100 | 329 | 14.1 | 0.00 % | 2.82 % | 0.24 % | 10.0 |
| Cyber Media (India) Ltd | 30.6 Cr. | 17.3 | 27.2/11.0 | 31.9 | 5.43 | 0.00 % | 4.52 % | % | 10.0 |
| Industry Average | 2,476.73 Cr | 125.22 | 235.67 | 37.13 | 0.22% | 15.66% | 12.68% | 6.15 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.80 | 0.00 | 0.00 | 0.43 | 0.00 | 0.01 | 0.02 | 0.02 | 0.03 | 11.47 | 4.63 |
| Expenses | 0.43 | 0.50 | 1.92 | 38.30 | 1.80 | 1.20 | 1.06 | 0.29 | 0.73 | 0.97 | 1.30 | 26.60 | 2.69 |
| Operating Profit | -0.43 | -0.50 | -1.12 | -38.30 | -1.80 | -0.77 | -1.06 | -0.28 | -0.71 | -0.95 | -1.27 | -15.13 | 1.94 |
| OPM % | -140.00% | -179.07% | -2,800.00% | -3,550.00% | -4,750.00% | -4,233.33% | -131.91% | 41.90% | |||||
| Other Income | 0.18 | 0.59 | 0.00 | 0.90 | 0.07 | 0.32 | 0.02 | 0.02 | 0.02 | 0.09 | 0.01 | 0.03 | 0.00 |
| Interest | 1.32 | 1.56 | 1.95 | 2.69 | 1.06 | 0.56 | 0.63 | 0.77 | 0.85 | 1.04 | 0.95 | 0.92 | 0.90 |
| Depreciation | 0.04 | 0.04 | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.06 | 0.05 |
| Profit before tax | -1.61 | -1.51 | -3.09 | -40.10 | -2.81 | -1.03 | -1.70 | -1.06 | -1.57 | -1.93 | -2.25 | -16.08 | 0.99 |
| Tax % | 0.00% | 0.00% | 0.00% | -45.71% | 0.00% | 0.00% | 0.00% | 86.79% | 0.00% | 0.00% | 0.00% | 60.88% | 0.00% |
| Net Profit | -1.61 | -1.52 | -3.09 | -21.77 | -2.80 | -1.03 | -1.69 | -1.97 | -1.57 | -1.93 | -2.25 | -25.87 | 0.99 |
| EPS in Rs | -0.28 | -0.26 | -0.54 | -3.79 | -0.49 | -0.18 | -0.29 | -0.34 | -0.27 | -0.34 | -0.39 | -4.50 | 0.17 |
Last Updated: August 1, 2025, 10:40 pm
Below is a detailed analysis of the quarterly data for Cinevista Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 4.63 Cr.. The value appears to be declining and may need further review. It has decreased from 11.47 Cr. (Mar 2025) to 4.63 Cr., marking a decrease of 6.84 Cr..
- For Expenses, as of Jun 2025, the value is 2.69 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 26.60 Cr. (Mar 2025) to 2.69 Cr., marking a decrease of 23.91 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.94 Cr.. The value appears strong and on an upward trend. It has increased from -15.13 Cr. (Mar 2025) to 1.94 Cr., marking an increase of 17.07 Cr..
- For OPM %, as of Jun 2025, the value is 41.90%. The value appears strong and on an upward trend. It has increased from -131.91% (Mar 2025) to 41.90%, marking an increase of 173.81%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.03 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.03 Cr..
- For Interest, as of Jun 2025, the value is 0.90 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.92 Cr. (Mar 2025) to 0.90 Cr., marking a decrease of 0.02 Cr..
- For Depreciation, as of Jun 2025, the value is 0.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.06 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.99 Cr.. The value appears strong and on an upward trend. It has increased from -16.08 Cr. (Mar 2025) to 0.99 Cr., marking an increase of 17.07 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 60.88% (Mar 2025) to 0.00%, marking a decrease of 60.88%.
- For Net Profit, as of Jun 2025, the value is 0.99 Cr.. The value appears strong and on an upward trend. It has increased from -25.87 Cr. (Mar 2025) to 0.99 Cr., marking an increase of 26.86 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.17. The value appears strong and on an upward trend. It has increased from -4.50 (Mar 2025) to 0.17, marking an increase of 4.67.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:30 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 52 | 59 | 41 | 24 | 21 | 35 | 19 | 1 | 1 | 1 | 0 | 12 | 20 |
| Expenses | 46 | 54 | 40 | 25 | 32 | 31 | 17 | 3 | 4 | 40 | 4 | 30 | 33 |
| Operating Profit | 6 | 5 | 1 | -1 | -11 | 5 | 2 | -2 | -3 | -40 | -4 | -18 | -13 |
| OPM % | 11% | 9% | 2% | -5% | -55% | 13% | 12% | -304% | -297% | -4,942% | -882% | -156% | -65% |
| Other Income | 0 | 0 | 5 | 7 | 15 | -0 | 0 | -2 | -7 | 1 | 0 | 0 | 0 |
| Interest | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 5 | 7 | 3 | 4 | 4 |
| Depreciation | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | -1 | 0 | 0 | -2 | -1 | -3 | -10 | -15 | -46 | -7 | -22 | -17 |
| Tax % | 28% | 15% | 0% | 25% | 1% | 2% | 1% | 0% | 11% | -40% | 14% | 45% | |
| Net Profit | 0 | -1 | 0 | 0 | -2 | -1 | -3 | -10 | -16 | -28 | -8 | -32 | -26 |
| EPS in Rs | 0.02 | -0.16 | 0.01 | 0.03 | -0.43 | -0.23 | -0.53 | -1.66 | -2.87 | -4.87 | -1.31 | -5.51 | -4.59 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 50.00% | -200.00% | -233.33% | -60.00% | -75.00% | 71.43% | -300.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -50.00% | -250.00% | -33.33% | 173.33% | -15.00% | 146.43% | -371.43% |
Cinevista Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -15% |
| 5 Years: | -10% |
| 3 Years: | 124% |
| TTM: | 3411% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -364% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 22% |
| 3 Years: | 7% |
| 1 Year: | -22% |
| Return on Equity | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | -15% |
| 3 Years: | -26% |
| Last Year: | -48% |
Last Updated: September 5, 2025, 2:00 am
Balance Sheet
Last Updated: December 4, 2025, 1:07 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| Reserves | 149 | 148 | 146 | 146 | 144 | 143 | 137 | 127 | 106 | 78 | 70 | 39 | 40 |
| Borrowings | 24 | 22 | 28 | 40 | 37 | 41 | 46 | 52 | 63 | 78 | 24 | 25 | 23 |
| Other Liabilities | 14 | 16 | 13 | 7 | 18 | 23 | 20 | 11 | 5 | 7 | 72 | 70 | 68 |
| Total Liabilities | 199 | 198 | 199 | 205 | 211 | 218 | 215 | 202 | 186 | 175 | 178 | 146 | 143 |
| Fixed Assets | 146 | 146 | 142 | 141 | 137 | 137 | 134 | 113 | 126 | 125 | 125 | 22 | 23 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 6 | 7 | 13 | 2 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 53 | 52 | 56 | 64 | 73 | 80 | 81 | 85 | 54 | 43 | 40 | 121 | 119 |
| Total Assets | 199 | 198 | 199 | 205 | 211 | 218 | 215 | 202 | 186 | 175 | 178 | 146 | 143 |
Below is a detailed analysis of the balance sheet data for Cinevista Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
- For Reserves, as of Sep 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 39.00 Cr. (Mar 2025) to 40.00 Cr., marking an increase of 1.00 Cr..
- For Borrowings, as of Sep 2025, the value is 23.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 25.00 Cr. (Mar 2025) to 23.00 Cr., marking a decrease of 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 68.00 Cr.. The value appears to be improving (decreasing). It has decreased from 70.00 Cr. (Mar 2025) to 68.00 Cr., marking a decrease of 2.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 143.00 Cr.. The value appears to be improving (decreasing). It has decreased from 146.00 Cr. (Mar 2025) to 143.00 Cr., marking a decrease of 3.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2025) to 23.00 Cr., marking an increase of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 119.00 Cr.. The value appears to be declining and may need further review. It has decreased from 121.00 Cr. (Mar 2025) to 119.00 Cr., marking a decrease of 2.00 Cr..
- For Total Assets, as of Sep 2025, the value is 143.00 Cr.. The value appears to be declining and may need further review. It has decreased from 146.00 Cr. (Mar 2025) to 143.00 Cr., marking a decrease of 3.00 Cr..
Notably, the Reserves (40.00 Cr.) exceed the Borrowings (23.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -18.00 | -17.00 | -27.00 | -41.00 | -48.00 | -36.00 | -44.00 | -54.00 | -66.00 | -118.00 | -28.00 | -43.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 117 | 85 | 150 | 300 | 172 | 112 | 180 | 4,700 | 2,491 | -0 | -0 | 0 |
| Inventory Days | 222 | 2,346 | ||||||||||
| Days Payable | 88 | 17 | ||||||||||
| Cash Conversion Cycle | 117 | 85 | 150 | 300 | 172 | 112 | 180 | 4,700 | 2,491 | 134 | -0 | 2,329 |
| Working Capital Days | 227 | 192 | 290 | 742 | 769 | 496 | 890 | 35,145 | 16,958 | 4,681 | -44,513 | 1,274 |
| ROCE % | 2% | 2% | 2% | 2% | 1% | 2% | 1% | 1% | -2% | -22% | -3% | -20% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | -5.37 | -1.27 | -4.75 | -2.80 | -1.62 |
| Diluted EPS (Rs.) | -5.37 | -1.27 | -4.75 | -2.80 | -1.62 |
| Cash EPS (Rs.) | -5.34 | -1.26 | -4.73 | -2.75 | -1.48 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -6.77 | -1.99 | -0.71 | 4.04 | 7.58 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 8.58 | 13.94 | 15.22 | 19.97 | 23.51 |
| Revenue From Operations / Share (Rs.) | 1.96 | 0.07 | 0.13 | 0.17 | 0.14 |
| PBDIT / Share (Rs.) | -3.04 | -0.58 | -6.50 | -0.50 | 0.35 |
| PBIT / Share (Rs.) | -3.07 | -0.60 | -6.52 | -0.56 | 0.21 |
| PBT / Share (Rs.) | -3.71 | -1.12 | -7.86 | -2.52 | -1.62 |
| Net Profit / Share (Rs.) | -5.37 | -1.27 | -4.75 | -2.80 | -1.62 |
| NP After MI And SOA / Share (Rs.) | -5.37 | -1.27 | -4.75 | -2.80 | -1.62 |
| PBDIT Margin (%) | -155.16 | -784.10 | -4784.16 | -294.43 | 248.70 |
| PBIT Margin (%) | -156.52 | -805.26 | -4798.60 | -325.02 | 153.61 |
| PBT Margin (%) | -189.13 | -1494.46 | -5789.27 | -1452.62 | -1138.45 |
| Net Profit Margin (%) | -273.90 | -1702.56 | -3498.06 | -1616.55 | -1138.69 |
| NP After MI And SOA Margin (%) | -273.90 | -1702.56 | -3498.06 | -1616.55 | -1138.69 |
| Return on Networth / Equity (%) | 0.00 | 0.00 | 0.00 | -69.35 | -21.36 |
| Return on Capital Employeed (%) | -24.05 | -3.35 | -33.96 | -1.83 | 0.67 |
| Return On Assets (%) | -21.71 | -4.20 | -15.98 | -8.88 | -4.72 |
| Long Term Debt / Equity (X) | -0.61 | -2.02 | -5.56 | 0.00 | 0.00 |
| Total Debt / Equity (X) | -0.62 | -2.06 | -5.56 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.07 | 0.00 | 0.00 | 0.01 | 0.00 |
| Current Ratio (X) | 1.59 | 0.28 | 0.36 | 15.71 | 7.44 |
| Quick Ratio (X) | 0.05 | 0.05 | 0.09 | 1.78 | 1.55 |
| Inventory Turnover Ratio (X) | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | -4.76 | -1.14 | -5.11 | -0.65 | 0.49 |
| Interest Coverage Ratio (Post Tax) (X) | -7.40 | -1.47 | -2.68 | -1.09 | 0.30 |
| Enterprise Value (Cr.) | 105.54 | 129.83 | 89.34 | 78.79 | 35.79 |
| EV / Net Operating Revenue (X) | 9.14 | 294.73 | 111.68 | 77.25 | 42.71 |
| EV / EBITDA (X) | -5.89 | -37.59 | -2.33 | -26.24 | 17.17 |
| MarketCap / Net Operating Revenue (X) | 7.06 | 243.81 | 88.00 | 77.74 | 42.96 |
| Price / BV (X) | -2.04 | -9.17 | -16.73 | 3.34 | 0.80 |
| Price / Net Operating Revenue (X) | 7.06 | 244.37 | 88.13 | 77.80 | 42.97 |
| EarningsYield | -0.38 | -0.06 | -0.39 | -0.20 | -0.26 |
After reviewing the key financial ratios for Cinevista Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -5.37. This value is below the healthy minimum of 5. It has decreased from -1.27 (Mar 24) to -5.37, marking a decrease of 4.10.
- For Diluted EPS (Rs.), as of Mar 25, the value is -5.37. This value is below the healthy minimum of 5. It has decreased from -1.27 (Mar 24) to -5.37, marking a decrease of 4.10.
- For Cash EPS (Rs.), as of Mar 25, the value is -5.34. This value is below the healthy minimum of 3. It has decreased from -1.26 (Mar 24) to -5.34, marking a decrease of 4.08.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -6.77. It has decreased from -1.99 (Mar 24) to -6.77, marking a decrease of 4.78.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 8.58. It has decreased from 13.94 (Mar 24) to 8.58, marking a decrease of 5.36.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1.96. It has increased from 0.07 (Mar 24) to 1.96, marking an increase of 1.89.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -3.04. This value is below the healthy minimum of 2. It has decreased from -0.58 (Mar 24) to -3.04, marking a decrease of 2.46.
- For PBIT / Share (Rs.), as of Mar 25, the value is -3.07. This value is below the healthy minimum of 0. It has decreased from -0.60 (Mar 24) to -3.07, marking a decrease of 2.47.
- For PBT / Share (Rs.), as of Mar 25, the value is -3.71. This value is below the healthy minimum of 0. It has decreased from -1.12 (Mar 24) to -3.71, marking a decrease of 2.59.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -5.37. This value is below the healthy minimum of 2. It has decreased from -1.27 (Mar 24) to -5.37, marking a decrease of 4.10.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -5.37. This value is below the healthy minimum of 2. It has decreased from -1.27 (Mar 24) to -5.37, marking a decrease of 4.10.
- For PBDIT Margin (%), as of Mar 25, the value is -155.16. This value is below the healthy minimum of 10. It has increased from -784.10 (Mar 24) to -155.16, marking an increase of 628.94.
- For PBIT Margin (%), as of Mar 25, the value is -156.52. This value is below the healthy minimum of 10. It has increased from -805.26 (Mar 24) to -156.52, marking an increase of 648.74.
- For PBT Margin (%), as of Mar 25, the value is -189.13. This value is below the healthy minimum of 10. It has increased from -1,494.46 (Mar 24) to -189.13, marking an increase of 1,305.33.
- For Net Profit Margin (%), as of Mar 25, the value is -273.90. This value is below the healthy minimum of 5. It has increased from -1,702.56 (Mar 24) to -273.90, marking an increase of 1,428.66.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -273.90. This value is below the healthy minimum of 8. It has increased from -1,702.56 (Mar 24) to -273.90, marking an increase of 1,428.66.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is -24.05. This value is below the healthy minimum of 10. It has decreased from -3.35 (Mar 24) to -24.05, marking a decrease of 20.70.
- For Return On Assets (%), as of Mar 25, the value is -21.71. This value is below the healthy minimum of 5. It has decreased from -4.20 (Mar 24) to -21.71, marking a decrease of 17.51.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -0.61. This value is below the healthy minimum of 0.2. It has increased from -2.02 (Mar 24) to -0.61, marking an increase of 1.41.
- For Total Debt / Equity (X), as of Mar 25, the value is -0.62. This value is within the healthy range. It has increased from -2.06 (Mar 24) to -0.62, marking an increase of 1.44.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.07. It has increased from 0.00 (Mar 24) to 0.07, marking an increase of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has increased from 0.28 (Mar 24) to 1.59, marking an increase of 1.31.
- For Quick Ratio (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.05.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.18, marking an increase of 0.18.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -4.76. This value is below the healthy minimum of 3. It has decreased from -1.14 (Mar 24) to -4.76, marking a decrease of 3.62.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -7.40. This value is below the healthy minimum of 3. It has decreased from -1.47 (Mar 24) to -7.40, marking a decrease of 5.93.
- For Enterprise Value (Cr.), as of Mar 25, the value is 105.54. It has decreased from 129.83 (Mar 24) to 105.54, marking a decrease of 24.29.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.14. This value exceeds the healthy maximum of 3. It has decreased from 294.73 (Mar 24) to 9.14, marking a decrease of 285.59.
- For EV / EBITDA (X), as of Mar 25, the value is -5.89. This value is below the healthy minimum of 5. It has increased from -37.59 (Mar 24) to -5.89, marking an increase of 31.70.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.06. This value exceeds the healthy maximum of 3. It has decreased from 243.81 (Mar 24) to 7.06, marking a decrease of 236.75.
- For Price / BV (X), as of Mar 25, the value is -2.04. This value is below the healthy minimum of 1. It has increased from -9.17 (Mar 24) to -2.04, marking an increase of 7.13.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.06. This value exceeds the healthy maximum of 3. It has decreased from 244.37 (Mar 24) to 7.06, marking a decrease of 237.31.
- For EarningsYield, as of Mar 25, the value is -0.38. This value is below the healthy minimum of 5. It has decreased from -0.06 (Mar 24) to -0.38, marking a decrease of 0.32.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cinevista Ltd:
- Net Profit Margin: -273.9%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -24.05% (Industry Average ROCE: 15.66%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 12.68%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -7.4
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.05
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 235.67)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -0.62
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -273.9%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Entertainment & Media | 1, Silver Croft, Off. T.P.S. III, Mumbai Maharashtra 400050 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Prem Krishen Malhotra | Chairman & Wholetime Director |
| Mr. Sunil Mehta | Vice Chairman & Mng.Director |
| Mrs. Vinita Concessio | Non Executive Director |
| Mrs. Rebekah Peter Martyres | Ind. Non-Executive Director |
| Mr. Dhiraj Labhchand Chaudhry | Ind. Non-Executive Director |
| Mr. Mahrukh Shavak Chikliwala | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Cinevista Ltd?
Cinevista Ltd's intrinsic value (as of 24 December 2025) is 53.13 which is 249.54% higher the current market price of 15.20, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 86.2 Cr. market cap, FY2025-2026 high/low of 24.9/12.9, reserves of ₹40 Cr, and liabilities of 143 Cr.
What is the Market Cap of Cinevista Ltd?
The Market Cap of Cinevista Ltd is 86.2 Cr..
What is the current Stock Price of Cinevista Ltd as on 24 December 2025?
The current stock price of Cinevista Ltd as on 24 December 2025 is 15.2.
What is the High / Low of Cinevista Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cinevista Ltd stocks is 24.9/12.9.
What is the Stock P/E of Cinevista Ltd?
The Stock P/E of Cinevista Ltd is .
What is the Book Value of Cinevista Ltd?
The Book Value of Cinevista Ltd is 9.10.
What is the Dividend Yield of Cinevista Ltd?
The Dividend Yield of Cinevista Ltd is 0.00 %.
What is the ROCE of Cinevista Ltd?
The ROCE of Cinevista Ltd is 19.9 %.
What is the ROE of Cinevista Ltd?
The ROE of Cinevista Ltd is 47.7 %.
What is the Face Value of Cinevista Ltd?
The Face Value of Cinevista Ltd is 2.00.